Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

This study has been terminated.
(Inability to reach enrollment as planned)
Information provided by (Responsible Party):
Alexion Pharmaceuticals Identifier:
First received: April 12, 2011
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)